X0303 4 2010-11-08 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001477287 Mulligan Margaret Jean 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 0 1 0 0 EVP, CFO Common Shares, no par value 2010-11-08 4 M 0 102658 0 A 130658 D Common Shares, no par value 2010-11-08 4 F 0 47644 26.12 D 83014 D Restricted Share Units 2010-11-08 4 M 0 51329 D 2010-11-08 2014-08-05 Common Shares, no par value 51329 0 D Each Restricted Share Unit ("RSU") represents a contingent right to receive one common share, no par value, of Valeant Pharmaceuticals International, Inc. and is subject to performance based vesting criteria, providing for vesting ranging from zero (0) to two hundred percent (200%). Represents performance based RSUs that accelerated at 200% in connection with the merger between the issuer (formerly known as Biovail Corporation) and Valeant Pharmaceuticals International and vested following the completion of the issuer's blackout period restrictions on November 8, 2010. Common shares withheld from the issuance of common shares to the Reporting Person to satisfy the tax withholding obligations due upon vesting of RSUs. By: Angie Palmer For: Margaret Mulligan 2010-11-10